在主要的呼吸道病毒感染中肝脏的参与
Piotr Rzymski1, Krystyna Dobrowolska2, Michał Brzdęk3,4
1Department of Environmental Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Clinical and experimental hepatology
|September 4, 2025
概括
像SARS-CoV-2,流感和RSV这样的呼吸系统病毒可以通过各种机制引起肝损伤. 早期识别和肝脏评估对于管理这些肺外症状至关重要,特别是在高风险患者中.
科学领域:
- 肝病学
- 病毒学
- 传染性疾病
背景情况:
- 众所周知,常见的呼吸道病毒,包括SARS-CoV-2,流感和RSV,会导致肺外并发症.
- 肝脏感染是这些病毒感染的越来越公认的表现,影响患者的预后.
研究的目的:
- 审查由SARS-CoV-2,流感和RSV引起的肝损伤的流行病学,机制和预后意义.
- 强调在呼吸道病毒感染中识别和管理肝脏参与的临床重要性.
主要方法:
- 对当前科学文献进行系统审查.
- 综合病毒性肝炎机制的证据,包括直接感染,炎症,缺氧和药物毒性.
- 对呼吸道病毒感染中肝损伤相关的临床数据和结果的分析.
主要成果:
- 多种机制导致肝功能障碍,从直接的病毒影响到间接的全身反应和药物诱导的肝损伤.
- 与流感或RSV相比,COVID-19相关的肝损伤受到了更多的研究,这表明研究缺口.
- 肝脏病需要临床治疗,特别是在易受伤害的人群中,如慢性肝脏病患者或移植患者.
结论:
- 识别和评估严重呼吸道病毒病患者的肝脏参与对于改善结果至关重要.
- 建议将肝脏评估纳入呼吸道病毒感染的治疗,特别是在高危人群中.
- 需要进一步的研究,以充分了解和管理与流感和RSV感染有关的肝损伤.
相关概念视频
Common Respiratory Disorders
893
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
893
Pneumonia II: Pathophysiology
533
The pathophysiology of pneumonia involves the following steps:
533
Acute Respiratory Failure-V
200
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
200
Acute Respiratory Failure-I
311
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
311
Acute Respiratory Failure-III
315
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
315
Acute Respiratory Failure-II
349
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
349


